Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Johnson and Johnson

Below is an extended Johnson and Johnson research listing. Click here to return to the Johnson and Johnson main Biocorporate entry.

Recent Publications by Johnson and Johnson:

Fluorescence and coloration of grey hair.
Grey hair samples were collected from 11 individuals and separated into...
18th November, 2009
Johnson and Johnson, Consumer Products Division, Skillman, NJ, USA. Int J Cosmet Sci. 2009 Oct;31(5):347-59.
DOI Direct Link
Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells.
BACKGROUND: Hematopoietic stem cells (HSC), in particular mobilized...
11th November, 2009
Johnson and Johnson Research Pty Ltd., Eveleigh, New South Wales, PLoS One. 2009 Jul 30;4(7):e6461.
DOI Direct Link
Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success.
BACKGROUND: Multiple short hairpin RNA (shRNA) gene therapy strategies are...
3rd November, 2009
Johnson and Johnson Research Pty Ltd, Level 4 Biomedical Building, Virol J. 2009 Oct 30;6:184.
DOI Direct Link
Pharmacometrics-Based Dose Selection of Levofloxacin as a Treatment for Post-Exposure Inhalational Anthrax in Children.
Levofloxacin was recently (May 2008) approved by U.S. Food and Drug...
28th October, 2009
Division of Pharmacometrics, Office of Clinical Pharmacology, Center for Antimicrob Agents Chemother. 2009 Oct 26.
DOI Direct Link
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.
BACKGROUND: MicroRNAs (MiRNAs) are short non-coding RNAs that control...
22nd October, 2009
Johnson and Johnson Research Pty Ltd, Eveleigh, NSW, Australia. BMC Cancer. 2009 Oct 20;9:374.
DOI Direct Link
Sequence determinants of innate immune activation by short interfering RNAs.
BACKGROUND: Short interfering RNAs (siRNAs) have been shown to induce...
22nd October, 2009
Johnson and Johnson Research Pty Ltd, Strawberry Hills, NSW, Australia. BMC Immunol. 2009 Jul 24;10:40.
DOI Direct Link
Role of Janus kinase-2 in IgE receptor-mediated leukotriene C(4) production by mast cells.
We have previously shown that Janus kinase 3, a member of the family of...
20th October, 2009
Johnson and Johnson Consumer and Personal Products Worldwide, Skillman, Biochem Biophys Res Commun. 2009 Oct 14.
DOI Direct Link
96 shRNAs designed for maximal coverage of HIV-1 variants.
BACKGROUND: The RNA interference (RNAi) pathway is a mechanism of...
6th October, 2009
Johnson and Johnson Research Pty Ltd, Australian Technology Park, Retrovirology. 2009 Jun 4;6:55.
DOI Direct Link
Primary leukocyte screens for innate immune agonists.
The innate immune system of mammals is a key defense mechanism against...
1st October, 2009
Johnson and Johnson Research Pty Ltd, Strawberry Hills NSW, Australia. J Biomol Screen. 2009 Jul;14(6):723-30. Epub 2009 Jun 12.
DOI Direct Link
The role of keratinocyte growth factor in melanogenesis: a possible mechanism for the initiation of solar lentigines.
Please cite this paper as: The role of keratinocyte growth factor in...
29th September, 2009
The Johnson and Johnson Skin Research Center, Consumer Product Worldwide, Exp Dermatol. 2009 Sep 23.
DOI Direct Link
An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(R) hydromorphone in patients with chronic cancer pain.
ABSTRACT: BACKGROUND: Opioid analgesics have proven efficacy in the...
17th September, 2009
Johnson and Johnson Pharmaceutical Research Division Corporation, 6500 BMC Palliat Care. 2009 Sep 15;8:14.
DOI Direct Link
Pharmacokinetics and pharmacodynamics of norfluoxetine in rats: Increasing extracellular serotonin level in the frontal cortex.
Norfluoxetine is the most important active metabolite of the widely used...
6th August, 2009
Johnson and Johnson Pharmaceutical Research and Development, L. L. C., Pharmacol Biochem Behav. 2009 May;92(3):469-73. Epub 2009 Feb 5.
DOI Direct Link
Heat-killed Propionibacterium acnes is capable of inducing inflammatory responses in skin.
Please cite this paper as: Heat-killed Propionibacterium acnes is capable...
25th July, 2009
Preclinical Pharmacology, Skin Research Center, Johnson and Johnson Exp Dermatol. 2009 Jul 14.
DOI Direct Link
A kinase-dead knock-in mutation in mTOR leads to early embryonic lethality and is dispensable for the immune system in heterozygous mice.
BACKGROUND: The mammalian target of rapamycin protein (mTOR) is an...
22nd May, 2009
Inflammation Research Team, Drug Discovery, Johnson and Johnson BMC Immunol. 2009 May 20;10:28.
DOI Direct Link
Cleaved secretory leucocyte protease inhibitor as a biomarker of chymase activity in allergic airway disease.
BACKGROUND: Secretory leucocyte protease inhibitor (SLPI), which is...
30th April, 2009
Johnson and Johnson Pharmaceutical Research and Development, Spring House, Clin Exp Allergy. 2009 Aug;39(8):1179-86. Epub 2009 Apr 7.
DOI Direct Link

«Johnson and Johnson

This page contained an extended Johnson and Johnson research listing. Click here to return to the Johnson and Johnson main Biocorporate entry.


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.